JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2015, 64(5):194-196 | DOI: 10.36290/csf.2015.043

Formulační aspekty orodispergovatelných tablet

Jan Stoniš*, Zdenka Šklubalová, Hana Hurychová, Pavel Ondrejček, Petra Svačinová
Univerzita Karlova v Praze, Farmaceutická fakulta v Hradci Králové, Katedra farmaceutické technologie, Hradec Králové, Česká republika

Published: May 1, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Stoniš J, Šklubalová Z, Hurychová H, Ondrejček P, Svačinová P. Formulační aspekty orodispergovatelných tablet. Čes. slov. farm. 2015;64(5):194-196. doi: 10.36290/csf.2015.043.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Ponugoti R. S. R., Gonugunta R. C. Formulation and evaluation of mouth dissolving tablets of tramadol hydrochloride. Trop. J. Pharm. Res. 2014; 13(5), 669-675. Go to original source...
    2. Parkash V., Deepika M. S., Yadav K. S., Jogpal H., Jogpal V. Fast disintegrating tablets: opportunity in drug delivery system. J. Adv. Technol. Res. 2011; 2(4), 223-235. Go to original source... Go to PubMed...
    3. Taher S. P., Sengupta M. Fast dissolving tablet technology - a review. World J. Pharma. Pharma. Sci. 2013; 2(2), 485-507.
    4. Shihora H., Panda S. Superdisintegrants, utility in dosage forms: A quick review. J. Pharma. Sci. Biosci. Res. 2011; 1(3), 148-153.
    5. Pein M., Preis M., Eckert C., Kiene E. F. Taste-masking assesment of solid dosage forms - a critical review. Int. J. Pharma. 2014; 465, 239-254. Go to original source... Go to PubMed...
    6. Manesh A. D., Shaikh R. S. Formulation and evaluation of desloratadine orodispersible tablets using β-cyklodextrine and superdisintegrants. J. Pharma. Res. 2011; 4(10), 3327-3330.
    7. Brniak W., Jachowicz R., Krupa A., Skorka T., Niwinski K. Evaluation of co-processed excipients used in direct compression of orally disintegrating tablets (ODT) using novel disintegration apparatus. Pharma. Dev. Tech. 2013; 18(2), 464-474. Go to original source... Go to PubMed...
    8. Bhowmik D., Chiranjib B., Pankaj K., Chandira R. M. Fast dissolving tablet: An overview. J. Chem. Pharma. Res. 2009; 1(1), 163-177.
    9. Abdelbary G., Prinderre P., Eouani C., Joachim J., Reynier P. J., Piccerelle P. Preparation of orally disintegrating tablets hydrophilic waxy binder. Int. J. Pharma. 2004; 278, 423-433. Go to original source... Go to PubMed...
    10. Kuno Y., Kojima M., Ando S., Nakagami H. Effect of preparation method on properties of orally disintegrating tablets made by the phase transition. Int. J. Pharma. 2008; 69, 87-92. Go to original source... Go to PubMed...
    11. Státní ústav pro kontrolu léčiv. Databáze léků. Dostupné z: http://www.sukl.cz/modules/medication/search.php (5. 6. 2015).
    12. Ministerstvo zdravotnictví ČR. Český lékopis 2009 - Doplněk 2014. 1. vydání. Praha: Grada Publishing 2014.
    13. Bi X. Y., Sunada H., Yonezawa Y., Danjo K. Evaluation of rapidly disintegrating tablets prepared by direct compression method. Drug Dev. Indstr. Pharma. 1999; 25(5), 571-581. Go to original source... Go to PubMed...
    14. Kaufhold S., Dohrmann R. Comparison of the traditional Enslin-Neff method and modified Dieng method for measuring water-uptake capacity. Clays and Clay Min. 2008; 56(6), 686-692. Go to original source...

    Return to the content


    Czech and Slovak Pharmacy

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.